Gastrointestinal Therapeutics

Induction of Emesis (Emetics)

Indication(s) - ingestion of toxicants, clean the stomach prior to emergency surgery

Contraindications do not induce vomiting if the patient has ingested caustics or petroleum products or if the patient has had recent abdominal surgery, if hernias are present, or if the patient is in severe abdominal pain.

NEW since 2008 Printed notes:
In human medicine, inducing vomiting is no longer recommended in cases of accidental or intentional posoining. Reasons for this include:

  1. Limited efficacy of the practice
  2. Vomiting may continue after the initial episode, making treatment of the poisoning difficult
  3. Recognition of hazards associated with typical emetics (ipecac)
  4. Abuse of ipecac (eating disorders, idiots on YouTube). It is actually unlikely that pet owners will have effective emetics available to them.
That said, it is not clear (to me) whether we should should or should not recommend that owners induce vomiting when pets have ingested poisons. For some poisonings (particularly things like a bottle full of pills), the practice would seem to have some merit. I'd recommend very selectively. By the way, it is not clear that activated charcoal is efficacious enough to warrant its use in these situations either.

Peripheral-acting emetics

Mechanism(s) - irritation of pharynx, esophagus, stomach, duodenum; or stretch of the muscular layer of the stomach or duodenum. Either mechanism evokes normal reflex arc to produce vomiting. These vary in reliability, safety, availability (do you have them).

Saturated sodium chloride solutions

1% copper sulfate

1% zinc sulfate

Neutral salts (sodium chloride, sodium bicarbonate)

Syrup of ipecac

Freshly ground mustard

Hydrogen peroxide

Central-acting emetics

Mechanism(s) - stimulation of chemoreceptor trigger zone (CRTZ) and/or direct stimulation of emetic center

Apomorphine

Morphine

Xylazine

Syrup of Ipecac

Control of Emesis

Rationale

  1. once vomiting is no longer serving in a protective capacity
  2. radiation therapy, cancer chemotherapy
  3. uremia, other "disease related toxins"
  4. severe abdominal pain (pancreatitis)

Peripheral-Acting Antiemetics

Demulcents - Kaolin, Pectin, Bismuth salts

Indication(s): control of vomiting associated with pharyngitis, gastritis. poor efficacy (may even stimulate vomiting)

Antacids - aluminum hydroxide, aluminum phosphate, magnesium hydroxide, etc.

Specific indication: vomiting associated with excess gastric acidity. Efficacy is questionable except to prevent recurrence (may stimulate vomiting in acute cases)

H-2 receptor antagonists - cimetidine, ranitidine, etc.

Specific Indication: vomiting associated with excess gastric acidity. Injectable dose forms will not stimulate vomiting so probably preferred over oral antacids

Local Anesthetics (e.g., Lidocaine viscous)

Specific Indication: vomiting associated with pharyngitis. Poor efficacy, may stimulate vomiting

Anticholinergics - aminopentamide, atropine, scopolamine

Indications are non-specific. Peripheral action alleged - block sensory input to CNS. Effective drugs in this class also have central action

Metoclopramide

Indications for regurgitation, pylorospasm. Improves coordination of motility and gastric emptying. Also possesses central action (CRTZ) described below

Central-acting antiemetics

Potential Sites of Action for the Central-acting antiemetics include the, vestibular apparatus, the chemoreceptor trigger zone (CRTZ), and the emetic center. Central-acting Anti-emetic drugs may be limited spectrum (one, maybe two sites) or broad spectrum (multiple or all sites).

Limited Spectrum Anti-emetics

Anticholinergic - aminopentamide (Centrine® ), scopolamine

Anti-histamines (H-1 receptor)

Short duration (4-8 hours) - diphenhydramine, dimenhydrinate

Long duration (12 -24 hours) - meclizine, promethazine

Trimethobenzamide

Metoclopramide

ondansetron, ganesetron (5-HT3 receptor blockers)

Maropitant (CereniaTM Dog); aprepitant (Emend Human) (NK-1 receptor blocker)

Broad-spectrum anti-emetics

block more than one site

Phenothiazines - chlorpromazine, acepromazine, prochlorperazine

Actions:
  1. block CRTZ at low doses
  2. block emetic center at high doses
Toxicities, contraindications:

Increase Gastrointestinal Motility

Gastrointestinal motility is influenced by hormonal activity, myogenic activity (contractile response to stretch), and neurogenic factors. It is divided into rhythmic segmentation (mixing activity and "average GI tone") and peristaltic activity (mainly propulsive).

Cholinergic Drugs

Rationale Cholinergic drugs are used for symptomatic treatment for diminished gastrointestinal motility (ruminal atony, abomasal displacement, ileus). Unfortunately they produce an uncoordinated increase in motility (coordinated would be preferred - see metoclopramide) You may see evidence of activity (abdominal pain, cramping) without improving patient condition

Pilocarpine

Bethanechol - (Urecholine®)

Carbachol

Pantethol

Cholinesterase inhibitors

These agents increase concentrations of acetycholine at the nerve terminal. The net effect is the same as if a direct-acting cholinergic agent were administered though the ultimate effect may be less predictable.

Physostigmine (tertiary amine)

Neostigmine (quarternary amine)

Cathartics, Surfactants, Lubricants

Indications these drugs are indicated for bowel cleansing (pre-surgical, pre-radiography, pre-proctoscopy), to promote elimination of toxicants, to facilitate defecation (hernias, surgeries) and to alleviate simple constipation

Irritant Cathartics

Mechanism stimulate smooth muscle directly

Contraindications

Arthroquinone derivatives - aloe, senna, cascara sagrada and danthron (synthetic)

Phenylphthalein

Bisacodyl

"Saline" Cathartics

  1. unabsorbed electrolytes which exert an osmotic effect (and)
  2. water moves from circulation ® fecal mass (which causes)
  3. stretch of mucosa and activation of "mechanoreceptors" (which)
  4. increases peristalsis

Sodium sulfate

Magnesium salts (oxide, hydroxide, sulfate)

Hydrophilic colloids (bran mash, linseed mash, psyllium)

Polyethylene Glycol Electrolyte (Go-LYTELY®)

Lubricants

Liquid petrolatum (mineral oil), petrolatum (vasoline, Cat-a-lax®)

Raw linseed oil

Surfactants

Mechanism non-irritating soaps that facilitate movement of water into fecal mass. These are classically referred to as "stool-softeners". Can be given as enemas or by mouth.

Caution. These may facilitate absorption of mineral oil when the two are given together

Dioctyl sodium sulfosuccinate and Dioctyl calcium sulfosuccinate

Prokinetic Agents

Metoclopramide

Mechanism Effect is probably mediated through both cholinergic systems enhanced and dopaminergic systems blocked.

Indications Pylorospasm and associated gastric reflux, presurgical emptying of the stomach, to facilitate passage of endoscope (maybe not in veterinary patients - per M.Leib), prevention of gastric dilatation and volvulus, displaced abomasum (investigational)

Cisapride

Mechanism Increase release of acetylcholine from postganglionic nerve endings of myenteric plexis. Both large and small bowel motility are enhanced

Indications Gastroesophageal reflux disease, Gastric atony uses in ileus, large bowel hypomotility speculative (clinical trials are sparse) but are probably appropriate given the limited number of alternatives.

"Investigational Prokinetics" - Erythromycin, Lidocaine

Alter gastrointestinal motility to control small bowel diarrhea.

Opiates

Mechanism(s)Increase tone in intestinal smooth muscle, increase rhythmic segmentation as compared to peristalsis, enhances fluid absorption, decreases average "lumen diameter". Decrease intestinal secretion (second action discussed later)

Indications Controlling signs of small bowel diarrhea

Loperamide (Imodium)

Diphenoxylate (Lomotil)

Paregoric (tincture of opium)

Decreased gastrointestinal motility

Management of drug induced "increased motility" or know these side effects when drugs are used for other purposes

Anticholinergic Drugs

Mechansim(s) Decrease parasympathetic tone in the gastrointestinal tract. Administration of these drugs is VERY questionable for the treatment of small bowel diarrhea, simply because gastrointestinal motility and associated disorders are controlled by a VERY complex set of neurogenic inputs that include a variety of other mediators. Further, many small bowel diarrheal diseases actually include low motility as a significant feature.

Indications Overzealous administration of cholinergic drugs and cholinesterase inhibiters, organophosphate and carbamate intoxication. Use in diarrhea may prolong clinical signs and may produce ileus (signs of which may include diarrhea)

atropine, scopolamine

methscopolamine, propanthaline, isopropamide (Darbazine®)

Adrenergic Drugs

Reduced GI motility is a side effect of administration for other purposes

a-1 agonists

b-2 agonists



Management of Severe Visceral Pain

Caution: although is is part of the veterinarian's oath to alleviate pain and suffering, pain may be the most (or only) useful clinical sign to the veterinary therapist as a guide to the animals response to other therapy. Relief of visceral pain should never be the ONLY therapy employed and may, in fact, be contraindicated early in the management of certain conditions.

Central Acting Analgesics

Mechanism(s) Raise the threshold for pain, decrease the reaction to pain, and promote drowsiness

Opiates / Opioids

Morphine

Methadone

Meperidine

Oxymorphone

Pentazocine

Butorphanol

Non-narcotic Analgesics

a 2 Agonists (Xylazine, Detomadine, Metdetomidine)

"Peripheral Acting Analgesics" - NSAIDS

Useful for the relief of visceral pain associated with intestinal spasm triggered by inflammatory mediators. Only flunixin meglumine and ketoprofen (of available agents) reduce gastrointestinal pain by other means. Mechanism of action of these compounds is discussed under anti-inflammatory drugs (http://cpharm.vetmed.vt.edu/VM8784/nsaids/nsaids.htm). Agents mentioned here enjoy special action or reputation for GI therapeutics.

Flunixin meglumine

Ketoprofen

Gastrointestinal secretion

Decrease flow of Saliva

see anesthesia notes

Decrease Gastric Acid Secretion

Anticholinergics
although these agents may decrease the secretion of gastric acid, there efficacy is very poor because acetylcholine is not a primary mediator for acid secretion

Anti-histamines (H-2 receptor blockers)

Cimetidine (Tagamet® )

Disadvantages Side Effects

Ranitidine (Zantac® )

Famotidine (Pepsid® )

Hydrogen ion-pump blockers

Omeprazole - (GastroGard® , Prilosec®, Nexium® AcipHex® , etc., etc.)

Mechanism block hydrogen ion secretion by direct inhibition of an ATPase

Indications Conditions related to hyperacidity refractory to other H-2 blockers. Approved indication in horses for treatment of gastric ulcers and prevention of recurrance.

Protect mucous membranes

Barium sulfate

Bismuth subsalicylate

Sucralfate

Misoprostol

Modify Intestinal Secretion

A number of different drug classes, including non-steroidal anti-inflammatories and opiates alter intestinal secretion. In fact, this may be a major mechanism of their activity in the treatment of small and large bowel diarrheas. In addition, oral electrolyte solutions serve as a valuable adjunct to therapy in neonatal diarrheas. Their primary activity is to maintain circulating blood volume, but they do so by fostering intestinal absorption of electrolytes and fluids in opposition to disease-induced secretion.

Topic Summary (Gastrointestinal Tract)

  1. Many acute gastrointestinal diseases (especially small animal) are self-limiting. In part, this explains why so many of us have faith in therapies that are not rational (anticholinergics for diarrhea).
  2. A wide variety of substances can be used to induce emesis by either peripheral or central actions. None of the emetics are absolutely reliable. The most reliable (and convenient) are apomorphine for dogs and xylazine in cats.
  3. The mechanism of action of anti-emetic drugs should be matched carefully to the cause of vomiting:

    Antihistamines vestibular motion sickness
    Phenothiazines CRTZ drug/toxin induced
    Phenothiazines Emetic Center all causes
    Metoclopramide CRTZ drug/toxin induced
    Metoclopramide Peripheral abn. GI function
    Butyrophenones Vestibular Labyrinthitis
    Butyrophenones Emetic Center All causes
  4. Few genuine indications for increasing gastrointestinal motility exist. Only metoclopramide produces a coordinated increase in motility of the upper gastrointestinal tract.
  5. Diarrhea is usually associated with hypomotility rather than hypermotility. For this reason anticholinergics are specifically contraindicated for the treatment of diarrhea. Opiates reduce symptoms by increasing rhythmic segmentation (and possibly by antisecretory mechanisms). This slows the rate of passage of ingesta.
  6. Visceral pain is best managed with central acting analgesics (opiates). Opiates do not relieve visceral pain in ruminants but xylazine does. A limited subset of NSAIDs (specifically banamine) may be potent enough to reduce visceral pain.
  7. Gastric acid secretion is reduced by the administration of H-2 blocking antihistamines (eg. cimetidine), H-pump blockers (omeprazole), and PGE2 analogues. PGE2 analogues have the additional benefit of stimulating the secretion of mucus.
  8. Oral electrolyte solutions are either isotonic or hypertonic. Relative benefits of either approach have not been studied systematically.